MapLight Therapeutics, Inc. MPLT
10.46
(0.30)
(2.79%)
as of 25 Sep
- Market cap
- $587.7M
- P/E
- 0.0×
Follow MPLT
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+4 more quarters Free account |
13.22 | 20.01 | 22.91 | 16.52 |
Net Debt/EBITDA |
7.14 | 3.60 | 4.76 | 4.73 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.08 | 0.59 | 0.84 | 0.75 | |
Capex/Depreciation |
0.09 | 0.29 | 0.04 | 0.03 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(40.22) | (5.44) | (1.13) | (0.99) | |
Cash per Share |
287.15 | 35.15 | 6.85 | 6.71 | |
Shareholders Equity per Share |
295.18 | 52.80 | 8.83 | 7.67 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
295.18 | 52.80 | 8.83 | 7.67 | |
Free Cash Flow |
(31.82) | (47.20) | (51.20) | (44.89) | |
Working Capital |
226.74 | 308.44 | 312.95 | 299.49 | |
Capital Expenditures |
(0.03) | (0.38) | (0.02) | (0.02) | |
Net Current Asset Value |
221.60 | 303.53 | 308.27 | 298.74 | |
| Other line items | |||||
Quick Ratio |
12.24 | 18.80 | 21.71 | 15.79 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(40.19) | (5.39) | (1.13) | (0.99) | |
Capex per Share |
(0.04) | (0.04) | 0.00 | 0.00 | |
Average Payables |
— | — | — | 1.98 | |
Average Assets |
128.61 | 239.76 | 209.39 | 184.17 | |
Average Common Equity |
— | — | — | 77.34 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates